StockWatch
·
Commodity Chemicals
Quarterly Result11 Feb 2026, 02:26 pm

Emmessar Biotech & Nutrition Ltd Announces Q3 Results for 2025

AI Summary

Emmessar Biotech & Nutrition Ltd, a company based in Maharashtra, India, has announced its unaudited financial results for the quarter ended 31st December 2025. The results were reviewed by the Audit Committee and approved by the Board of Directors at their meeting held on 11th February 2026. The company operates in two segments: Healthcare and Rent on Leasehold Land. No investor complaints were received during the quarter. The results are in compliance with the Indian Accounting Standards and the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015. The company will continue to monitor the impact of the recently notified Labour Codes.

Key Highlights

  • Q3 results for 2025 announced
  • Revenue from Healthcare and Rent on Leasehold Land segments
  • Reviewed by Audit Committee and approved by Board of Directors
  • Compliance with Indian Accounting Standards and SEBI regulations
  • No investor complaints received during the quarter